Pelubiprofen Explained
Tradename: | Pelubi |
Atc Prefix: | None |
Legal Status: | Rx in several countries |
Cas Number: | 69956-77-0 |
Pubchem: | 5282203 |
Unii: | 1619C79FVJ |
Drugbank: | DB12150 |
Stdinchi: | 1S/C16H18O3/c1-11(16(18)19)13-8-6-12(7-9-13)10-14-4-2-3-5-15(14)17/h6-11H,2-5H2,1H3,(H,18,19)/b14-10+ |
Stdinchikey: | AUZUGWXLBGZUPP-GXDHUFHOSA-N |
Smiles: | CC(C1=CC=C(C=C1)/C=C/2\CCCCC2=O)C(=O)O |
Iupac Name: | 2-[4-[(''E'')-(2-Oxocyclohexylidene)methyl]phenyl]propanoic acid |
C: | 16 |
H: | 18 |
O: | 3 |
Pelubiprofen is a nonsteroidal anti-inflammatory drug of the profen class used to treat back pain and osteoarthritis.[1]
Pelubiprofen was developed in South Korea by Daewon Pharmaceuticals and it is marketed in Korea and Russia,[2] among other countries.
Research
Pelubiprofen is being studied for use in combination with eperisone.[3]
Because pelubiprofen has low water solubility, development of salt formulations with better solubility are being studied.[4]
Synthesis
Pelubiprofen can be prepared by the reaction of 1-(1-piperidino)cyclohexene (1) with ethyl 2-(4-formylphenyl)propanoate (2).[5] [6] [7] [8] [9] [10] [11]
Notes and References
- Web site: Pelubiprofen - Daewon Pharmaceutical . AdisInsight . Springer Nature Switzerland AG .
- News: Chan-Hyuk K . Daewon Pharm wins $3 million deal to export Pelubi to Indonesia . 26 September 2023 . Korea Biomedial Review .
- Web site: (Eperisone + pelubiprofen) by Daewon Pharmaceutical for Low Back Pain: Likelihood of Approval . pharmaceutical-technology.com . 5 June 2023 .
- Park JY, Oh DH, Park SW, Chae BR, Kim CW, Han SH, Shin HJ, Yeom SB, Lee DY, Park MK, Park SE, Park JB, Lee KT . Development of Pelubiprofen Tromethamine with Improved Gastrointestinal Safety and Absorption . Pharmaceutics . 13 . 5 . 745 . May 2021 . 34070062 . 8158122 . 10.3390/pharmaceutics13050745 . free .
- Serradell, MN; Castaer, J.; RS-2131. Drugs Fut 1984, 9, 4, 275.
- Terada, Atsusuke; Naruto, Shunji; Wachi, Kazuyuki; Tanaka, Shigeru; Iizuka, Yoshio; Misaka, Eiichi (1984). "Synthesis and antiinflammatory activity of [(cycloalkylmethyl)phenyl]acetic acids and related compounds". Journal of Medicinal Chemistry. 27 (2): 212–216. doi:10.1021/jm00368a019.
- Atsusuke Terada, Shigeru Tanaka, & Eiichi Misaka, US4254274 (1981 to Sankyo Co Ltd).
- Yuan Weiguan, et al. CN111153791 (2020 to HUNAN JIUDIAN HONGYANG PHARMACEUTICAL Co., Ltd).
- Yuan Weiguan, et al. WO2021129651 (to Hunan Jiudian Pharmaceutical Co Ltd).
- Ning Hulin, et al. CN110041191 (2019 to HUNAN JIUDIAN HONGYANG PHARMACEUTICAL Co., Ltd.).
- https://www.chemdrug.com/article/8/3284/16419229.html ChemDrug